Cargando…

Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells

Ovarian cancer is a fatal gynecological malignancy. Although first-line chemotherapy and surgical operation are effective treatments for ovarian cancer, its clinical management remains a challenge owing to intrinsic or acquired drug resistance and relapse at local or distal lesions. Cancer stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wookyeom, Kim, Dasol, Kim, Dae Kyoung, Choi, Kyung Un, Suh, Dong Soo, Kim, Jae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151268/ https://www.ncbi.nlm.nih.gov/pubmed/34064635 http://dx.doi.org/10.3390/ijms22105059

Ejemplares similares

Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer
por: Lee, Seoyul, et al.
Publicado: (2022)

TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells
por: Kang, Kyung Taek, et al.
Publicado: (2018)

Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells
por: Lee, Heejin, et al.
Publicado: (2020)

CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis
por: Kim, Jun Se, et al.
Publicado: (2023)

FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells
por: Choi, Eun Jung, et al.
Publicado: (2015)

CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells
por: Kim, Dae Kyoung, et al.
Publicado: (2020)

Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer
por: Seo, Eun Jin, et al.
Publicado: (2016)

Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells
por: Kim, Dae Kyoung, et al.
Publicado: (2016)

TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis
por: Kim, Dae Kyoung, et al.
Publicado: (2021)

TRRAP Enhances Cancer Stem Cell Characteristics by Regulating NANOG Protein Stability in Colon Cancer Cells
por: Kang, Kyung-Taek, et al.
Publicado: (2023)

The Role of TWIST in Ovarian Epithelial Cancers
por: Kim, Kyungbin, et al.
Publicado: (2014)

Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma
por: Shin, Ha‐Yeon, et al.
Publicado: (2021)

An unusual case of pedunculated subserosal leiomyosarcoma of the uterus mimicking ovarian carcinoma
por: Suh, Dong Soo, et al.
Publicado: (2016)

Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
por: Kim, So Young, et al.
Publicado: (2019)

Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting
por: Kim, Hyun Jung
Publicado: (2022)

Application of periostin peptide-decorated self-assembled protein cage nanoparticles for therapeutic angiogenesis
por: Kim, Ba Reun, et al.
Publicado: (2022)

Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma
por: Hwang, Chungsu, et al.
Publicado: (2019)

Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers
por: Kim, Ki Hyung, et al.
Publicado: (2012)

Identification of therapeutic targets applicable to clinical strategies in ovarian cancer
por: Kim, Marianne K., et al.
Publicado: (2016)

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
por: Kwon, Byung Su, et al.
Publicado: (2018)

Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
por: Yang, Wookyeom, et al.
Publicado: (2016)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients
por: Aiob, Ala, et al.
Publicado: (2023)

Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes
por: Kim, Ye Seul, et al.
Publicado: (2020)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Ovarian Cavernous Hemangioma Presenting as a Large Growing Mass in a Postmenopausal Woman: A Case Report and Review of the Literature
por: Kim, Sun Suk, et al.
Publicado: (2015)

MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer
por: Cho, Jin Gu, et al.
Publicado: (2022)

Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
por: Kim, Tae Hun, et al.
Publicado: (2014)

Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
por: Terraneo, Nastassja, et al.
Publicado: (2020)

TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels
por: Yang, Wookyeom, et al.
Publicado: (2020)

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
por: Kim, Ha-Jeong, et al.
Publicado: (2016)

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

Recent advances in stem cell therapeutics and tissue engineering strategies
por: Kwon, Seong Gyu, et al.
Publicado: (2018)

Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
por: Choi, Jung-A, et al.
Publicado: (2023)

Therapeutic strategies targeting folate receptor α for ovarian cancer
por: Mai, Jia, et al.
Publicado: (2023)

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
por: Eoh, Kyung Jin, et al.
Publicado: (2018)

Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells
por: Oh, Se Jin, et al.
Publicado: (2015)

Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
por: Sun, Hao-Ran, et al.
Publicado: (2019)

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
por: Kang, Hyunkoo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mao5ah73d1ngch8g3269ccva3g